跳至主要内容
临床试验/NCT02465996
NCT02465996Unknown不适用

Gastric Barrier Dysfunction of Functional Dyspepsia and Therapeutic Response to Puyuanhewei Detected by Endomicroscopy

Shandong University1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2014年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
200
试验地点
1
主要终点
pCLE score

研究概览

简要总结

Functional dyspepsia might have impaired gastric mucosal dysfunction and Puyuanhewei may be helpful to improve the symptoms of FD.

详细描述

This study aimed to investigate the gastric mucosal dysfunction in functional dyspepsia (FD) and verify the efficacy of Puyuanhewei for treating FD and assess the relationship between gastric microalterations and therapeutic response by endomicroscopy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Consecutive outpatients aged 18 to 75 years old.
  • FD patients defined by the Rome III classification.
  • Willing to choose pCLE and no organic diseases.

排除标准

  • Severe liver, heart, or kidney diseases.
  • Current or past evidence of uncontrolled diabetes mellitus, psychosomatic disorders, such as depressive and anxiety disorders, and drug or alcohol abuse.
  • Pregnant or breastfeeding women.
  • Inability to give informed consent.
  • Use of nonsteroidal anti-inflammatory drugs, proton pump inhibitors, H2-receptor antagonists, antacids, prokinetics, or other injurious drugs (antibiotics, and steroids) in the prior two weeks.

研究组 & 干预措施

postprandial distress syndrome (PDS)

Other

FD patients fulfilled Rome III criteria were subclassified into postprandial distress syndrome (PDS) or epigastric pain syndrome (EPS).

pCLE examination was performed in PDS patients, and then those who were willing to receive Puyuanhewei to treat FD were given 4 pills three times a day for 4 weeks after pCLE examination.

干预措施: pCLE examination (Device)

postprandial distress syndrome (PDS)

Other

FD patients fulfilled Rome III criteria were subclassified into postprandial distress syndrome (PDS) or epigastric pain syndrome (EPS).

pCLE examination was performed in PDS patients, and then those who were willing to receive Puyuanhewei to treat FD were given 4 pills three times a day for 4 weeks after pCLE examination.

干预措施: Puyuanhewei (Drug)

epigastric pain syndrome (EPS)

Other

pCLE examination was performed in EPS patients, and then those who were willing to receive Puyuanhewei to treat FD were given 4 pills three times a day for 4 weeks after pCLE examination.

干预措施: pCLE examination (Device)

epigastric pain syndrome (EPS)

Other

pCLE examination was performed in EPS patients, and then those who were willing to receive Puyuanhewei to treat FD were given 4 pills three times a day for 4 weeks after pCLE examination.

干预措施: Puyuanhewei (Drug)

结局指标

主要结局

pCLE score

时间窗: within 1 hour after pCLE examination

Used to assess the gastric barrier dysfunction of FD patients

次要结局

  • Leeds dyspepsia questionaire(baseline and 4th week)
  • Main dyspepsia symptom score(baseline and 4th weeks)

研究者

发起方
Shandong University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Yanqing Li

Vice president of Qilu Hospital

Shandong University

研究点 (1)

Loading locations...

相似试验